Combined Figures SIX & BME |
December |
MoM change |
YoY change |
YTD |
YTD change |
Turnover* in CHF million |
108,804 |
-16.6% |
-4.6% |
1,582,659 |
5.6% |
Turnover* in EUR million |
116,257 |
-17.2% |
-5.0% |
1,691,071 |
5.1% |
Transactions* |
5,669,678 |
-15.6% |
-4.1% |
77,942,376 |
4.3% |
SMI® |
11,600.9 |
-1.4% |
4.2% |
n.a. |
4.2% |
IBEX35® |
11,595 |
-0.4% |
14.8% |
n.a. |
14.8% |
*includes all respective trading segments for SIX Swiss Exchange and BME Exchange except Financial Derivatives; exchange rate provided by the SIX currency converter, For indices, “YTD Change” refers to the change since beginning of the year,
BME
The Spanish equity market closed the year with a 6% increase in trading volume to 318,005 million euros, after successfully completing the incorporation of three companies into its main market: Puig, Inmocemento and Cox. At December 31, the Spanish stock market had a capitalization of 1.3 trillion, up 0.94% on the previous year. The IBEX35® also followed this positive trend, rising by 14.8%. Including dividends distributed, the index's total return reached 20%. At the end of the year, BME announced the launch of SpainAtMid, a new non-pre-transparency order book to make trading Spanish equities more attractive.
The BME Growth and BME Scaleup markets added 23 companies in 2024, with a total volume of 573.5 million euros in capital increases.
A total of 22,160 transactions were executed in BME's secondary fixed-income markets for an amount of close to 104 billion euros. New issues in the AIAF market channeled more than 360 billion euros of financing to the public and private sector. The MARF market received 14 new issuers and reached the figure of 161 companies that have used this market since its launch in 2013. The total volume issued was 16,583 million euros. Overall, 18 new green, social or sustainable bond issues by Spanish issuers were admitted to all BME's fixed-income markets during 2024.
The MEFF Derivatives market continued to improve its range of products and services for its clients and ended the year with an increase of 45.7% in accumulated volume in the year in IBEX 35 Options, while trading in Energy Derivatives increased by 27.9%.
BME (turnover in EUR million) |
December |
MoM change |
YoY change |
YTD |
YTD change |
|
||||||
Turnover Equities |
23,781 |
-13.7% |
5.6% |
318,005 |
6.0% |
|
||||||
Turnover Fixed Income |
4,724 |
-44.3% |
-29.4% |
103,908 |
-43.5% |
|
||||||
Turnover ETFs |
83 |
24.5% |
6.6% |
992 |
-23.6% |
|
||||||
Turnover Securitized Derivatives |
19 |
-25.2% |
-19.6% |
296 |
-22.5% |
|
||||||
Turnover total |
28,607 |
-20.8% |
-2.4% |
423,200 |
-12.9% |
|
||||||
|
|
|
|
|
|
|||||||
Transactions Equities |
2,114,064 |
-17.1% |
-7.8% |
29,865,251 |
5.0% |
|
||||||
Transactions Fixed Income |
1,060 |
-29.8% |
-35.2% |
22,160 |
-30.0% |
|
||||||
Transactions ETFs |
4,932 |
13.3% |
5.6% |
62,841 |
-26.3% |
|
||||||
Trans, Securitized Derivatives |
3,292 |
-18.0% |
10.0% |
45,728 |
-15.4% |
|
||||||
Transactions total |
2,123,348 |
-17.1% |
-7.7% |
29,995,980 |
4.8% |
|
||||||
|
|
|
|
|
|
|||||||
Nº Product Listed Fixed Income |
287 |
5.5% |
-1.0% |
3,881 |
-32.4% |
|
||||||
Capital listed via Fixed Income |
35,368.0 |
31.7% |
48.3% |
367,404.3 |
-9.4% |
|
||||||
Nº Prod, Listed Secur, Derivatives |
0 |
0.0% |
0.0% |
6,379 |
-8.6% |
|
||||||
|
|
|
|
|
|
|
||||||
BME Financial Derivatives Traded contracts |
December |
MoM change |
YoY change |
YTD |
YTD change |
Turnover (Mill Eur) |
||||||
IBEX 35® Future |
389 |
-2.8% |
2.8% |
4,525 |
-2.0% |
45,490 |
||||||
Mini IBEX 35® Future |
44 |
-18.5% |
17.4% |
617 |
0.7% |
520 |
||||||
IBEX 35® Options |
118 |
11.1% |
26.1% |
815 |
45.7% |
1,310 |
||||||
Stock Futures |
1,023 |
-55.9% |
-6.0% |
11,473 |
1.7% |
63 |
||||||
Stock Options |
1,358 |
96.8% |
-1.3% |
10,994 |
-14.2% |
1,508 |
||||||
Power Derivatives (MW) |
191 |
-69.9% |
-73.9% |
6,104 |
27.9% |
14 |
||||||
Index |
December |
MoM change |
YTD change |
IBEX 35® |
11,595 |
-0.4% |
14.8% |
IBEX® Medium Cap |
15,138 |
2.2% |
11.7% |
IBEX® Small Cap |
8,149 |
2.2% |
2.6% |
IBEX® Growth 15 |
1,346 |
-8.0% |
-25.5% |
Vibex® |
13 |
-3.5% |
8.0% |
SIX
In the year 2024, two companies chose to issue and list equity securities on SIX Swiss Exchange: Galderma with a market capitalization of CHF 14.5 bn and Sunrise with CHF 3.2 bn. Galderma’s placement volume was around CHF 2.0 billion (excluding over-allotment option) which represents the largest IPO placement in Switzerland since 2017.
Equally important is the fact that companies that are already listed made active use of the Swiss capital market and were able to raise around CHF 2.3 billion via equity capital increases in the past year.
2024 was a strong year for raising debt capital with bonds. Around CHF 104 billion (CHF 116 billion in 2023) were raised, exceeding the CHF 100 billion mark for the third time in a row. In total, the bond segment saw 453 new listings (436 in 2023).
In the product segments, six new issuers joined SIX Swiss Exchange over the course of the year: the ETF issuer abrdn Investments, the ETP issuers Issuance.Swiss, UBS, HANetf and DWS Xtrackers, as well as the investment fund issuer Helvetia Asset Management.
In 2024, the number of ETFs available to investors surpassed the previous year’s record, with 1,885, while structured products reached 60,000 again. For the second time in a row, the number of newly listed structured products in a year passed the 100,000 threshold, reaching the new record of 110,792 (2023: 102,504), while 254 new ETFs were listed (2023: 150).
SIX (turnover in CHF million) |
December |
MoM change |
YoY change |
YTD |
YTD change |
Turnover Equities** |
58,921 |
-15.6% |
2.0% |
791,851 |
-1.3% |
Turnover Fixed Income |
12,491 |
-25.7% |
-45.8% |
301,559 |
75.7% |
Turnover ETFs |
9,890 |
6.4% |
83.9% |
84,149 |
31.0% |
Turn, Securitized Derivatives |
729 |
-28.5% |
23.3% |
9,031 |
12.8% |
Turnover total |
82,031 |
-15.4% |
-5.5% |
1,186,590 |
13.4% |
|
|
|
|
|
|
Transactions Equities** |
26,124 |
-15.2% |
-24.8% |
407,790 |
-7.8% |
Transactions Fixed Income |
235,363 |
-4.9% |
55.8% |
2,471,174 |
44.1% |
Transactions ETFs |
32,173 |
-20.2% |
11.5% |
446,078 |
14.8% |
Trans. Secur. Derivatives |
3,546,330 |
-14.6% |
-1.8% |
47,946,396 |
4.0% |
Transactions total |
26,124 |
-15.2% |
-24.8% |
407,790 |
-7.8% |
|
|
|
|
|
|
Nº Product Listed Fixed Income |
14 |
-65.9% |
-41.7% |
453 |
3.9% |
Capital Raised via Fixed Income* |
2,564 |
-58.6% |
-50.9% |
103,822 |
-10.2% |
Nº Product Listed Secur. Derivatives |
9,143 |
-7.3% |
2.3% |
110,792 |
8.1% |
* million CHF
|
Index |
December |
MoM change |
YTD change |
SMI® PR |
11,600.9 |
-1.4% |
4.2% |
SLI Swiss Leader Index® PR |
1,917.1 |
-1.2% |
7.9% |
SMIM® PR |
2,618.9 |
-0.2% |
2.1% |
SPI® TR |
15,472.3 |
-1.3% |
6.2% |
SPI EXTRA® TR |
5,151.0 |
-0.8% |
3.8% |
SXI LIFE SCIENCES® TR |
6,963.4 |
-2.0% |
13.7% |
SXI Bio+Medtech® TR |
4,357.5 |
-2.4% |
-4.6% |
SBI® AAA-BBB Total Return |
138.5 |
-0.2% |
5.4% |